Marka R. Crittenden
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy
Crittenden, Marka R.; Baird, Jason; Friedman, David; Savage, Talicia; Uhde, Lauren; Alice, Alejandro; Cottam, Benjamin; Young, Kristina; Newell, Pippa; Nguyen, Cynthia; Bambina, Shelly; Cramer, Gwen; Akporiaye, Emmanuel; Malecka, Anna; Jackson, Andrew ; Gough, Michael J.
Authors
Jason Baird
David Friedman
Talicia Savage
Lauren Uhde
Alejandro Alice
Benjamin Cottam
Kristina Young
Pippa Newell
Cynthia Nguyen
Shelly Bambina
Gwen Cramer
Emmanuel Akporiaye
Miss ANNA MALECKA ANNA.MALECKA1@NOTTINGHAM.AC.UK
ASSISTANT PROFESSOR IN IMMUNOLOGY
Dr ANDREW JACKSON ANDREW.JACKSON@NOTTINGHAM.AC.UK
ASSOCIATE PROFESSOR
Michael J. Gough
Abstract
Radiation therapy provides a means to kill large numbers of cancer cells in a controlled location resulting in the release of tumor-specific antigens and endogenous adjuvants. However, by activating pathways involved in apoptotic cell recognition and phagocytosis, irradiated cancer cells engender suppressive phenotypes in macrophages. We demonstrate that the macrophage-specific phagocytic receptor, Mertk is upregulated in macrophages in the tumor following radiation therapy. Ligation of Mertk on macrophages results in anti-inflammatory cytokine responses via NF-kB p50 upregulation, which in turn limits tumor control following radiation therapy. We demonstrate that in immunogenic tumors, loss of Mertk is sufficient to permit tumor cure following radiation therapy. However, in poorly immunogenic tumors, TGFb inhibition is also required to result in tumor cure following radiation therapy. These data demonstrate that Mertk is a highly specific target whose absence permits tumor control in combination with radiation therapy.
Citation
Crittenden, M. R., Baird, J., Friedman, D., Savage, T., Uhde, L., Alice, A., Cottam, B., Young, K., Newell, P., Nguyen, C., Bambina, S., Cramer, G., Akporiaye, E., Malecka, A., Jackson, A., & Gough, M. J. (2016). Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy. Oncotarget, 7(48), 78653-78666. https://doi.org/10.18632/oncotarget.11823
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 25, 2016 |
Online Publication Date | Sep 2, 2016 |
Publication Date | Nov 29, 2016 |
Deposit Date | May 24, 2017 |
Publicly Available Date | May 24, 2017 |
Journal | Oncotarget |
Electronic ISSN | 1949-2553 |
Publisher | Impact Journals |
Peer Reviewed | Peer Reviewed |
Volume | 7 |
Issue | 48 |
Pages | 78653-78666 |
DOI | https://doi.org/10.18632/oncotarget.11823 |
Keywords | radiation, macrophage, tumor, phagocytosis, apoptosis |
Public URL | https://nottingham-repository.worktribe.com/output/819382 |
Publisher URL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346667/ |
Contract Date | May 24, 2017 |
Files
2016 Oncotarget Mertk Radiotherapy.pdf
(2.3 Mb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
EPEN-08. THE TREM1 POSITIVE HYPOXIC MYELOID SUBPOPULATION IN POSTERIOR FOSSA EPENDYMOMA
(2021)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search